Triple

T4689780
Position Surface form Disambiguated ID Type / Status
Subject BCG vaccine E104005 entity
Predicate seriousAdverseEvent P24552 FINISHED
Object disseminated BCG infection in severely immunocompromised individuals LITERAL FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: disseminated BCG infection in severely immunocompromised individuals | Statement: [BCG vaccine, seriousAdverseEvent, disseminated BCG infection in severely immunocompromised individuals]
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: seriousAdverseEvent
Context triple: [BCG vaccine, seriousAdverseEvent, disseminated BCG infection in severely immunocompromised individuals]
  • A. commonAdverseReactions
    Indicates that the related entities are linked through adverse reactions or side effects that frequently occur in association with one another.
  • B. hasSeriousSideEffect chosen
    Indicates that an entity (such as a treatment, drug, or intervention) causes or is associated with a significant or severe adverse effect on another entity (typically a patient or biological system).
  • C. hasCommonAdverseEffect
    Indicates that two or more entities share at least one adverse effect that occurs in response to them.
  • D. notableToxicity
    Indicates that an entity is recognized for having a significant level or history of toxicity, harm, or detrimental effects in its context or interactions.
  • E. observationSafety
    Indicates that an observation or monitoring activity is conducted in a manner that ensures the safety of the subjects, observers, and environment involved.
  • F. None of above.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69bd43df91f481908e9add1b617b60ef completed March 20, 2026, 12:55 p.m.
NER Named-entity recognition batch_69bd66059bfc8190885d26d05dd38df1 completed March 20, 2026, 3:21 p.m.
PD Predicate disambiguation batch_69bd6219da948190bbbb50f08573ab4d completed March 20, 2026, 3:04 p.m.
Created at: March 20, 2026, 1:16 p.m.